Gujarat Kidney IPO Analyzed: What It Means for Investors

The Gujarat Kidney and Super Speciality hospital stock started trading on the stock market, but it didn’t perform as expected. It was initially priced higher than the sale price, but investors quickly sold their shares, causing the price to drop by 8%. This means the stock finished the first day of trading at ₹105, which is 5.2% lower than the price it was sold for.

Key Points

• Stock debut down 8%, lower than initial sale price.
• Strong initial listing at 5.2% premium to IPO.
• Market cap now ₹825 crore after listing activity.
• IPO raised ₹251 crore for hospital expansion and debt.
• Record IPO activity: 103 companies listed in 2025.
• Despite market volatility, IPOs continue to thrive strongly.

About the IPO

The company raised money by selling shares in an IPO (Initial Public Offering). The sale price was set between ₹108 and ₹114 per share. All the money raised – ₹251 crore – is being used to grow the hospital chain and pay off debts.

What the Company Plans to Do

Gujarat Kidney operates hospitals across India. They have a total of 340 beds. The company is using the money from the IPO for several things, including buying more hospitals, paying for hospitals they’ve already purchased, expanding their existing hospitals, and paying back loans.

The Big Picture – Why So Many IPOs?

This IPO listing happened during a really busy time for the stock market in India. In 2025, a record-breaking 103 companies have already gone public – the most in 25 years! This is happening even though the regular stock market has been a little shaky, and there’s some uncertainty about trade deals.

Looking Ahead

Experts believe this strong activity in the IPO market could continue for a while. Usually, after a big boom in IPOs, the market gets quieter. However, companies are still raising money despite some market challenges, suggesting investors are still confident in India’s economy.

This IPO listing is a signal that investors are still willing to back healthcare companies, even amidst market uncertainty.